The Use of Intralipid Infusions in the Prevention of Embryo Implantation Failure

Intralipids have been suggested to suppress uterine natural killer cell activity, which could potentially improve implantation rates in women with recurrent loss. We report a case of a 41-year-old African woman with recurrent pregnancy loss who had elevated uterine killer cell activity and for whom...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Curēus (Palo Alto, CA) CA), 2024-02, Vol.16 (2), p.e53368
Hauptverfasser: Anya, Okorie C, Ajayi, Eniola R, Solanke, Henry R, Ohanaka, Adaeze I, Ubana, Kokei D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page e53368
container_title Curēus (Palo Alto, CA)
container_volume 16
creator Anya, Okorie C
Ajayi, Eniola R
Solanke, Henry R
Ohanaka, Adaeze I
Ubana, Kokei D
description Intralipids have been suggested to suppress uterine natural killer cell activity, which could potentially improve implantation rates in women with recurrent loss. We report a case of a 41-year-old African woman with recurrent pregnancy loss who had elevated uterine killer cell activity and for whom intralipid infusion was used to achieve pregnancy. We recommend routine uterine natural killer cell testing for women with recurrent pregnancy loss and further research on newer intravenous lipid emulsions in fertility medicine.
doi_str_mv 10.7759/cureus.53368
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3020718241</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3020718241</sourcerecordid><originalsourceid>FETCH-LOGICAL-c211t-5b9a1fe10cda0530bf437063e06ae72d10187208d70ab43b6cb7676fca8c6caa3</originalsourceid><addsrcrecordid>eNpNkM1LAzEQxYMoVmpvnmXBq1tnNrtJepTSaqFgD-05ZLMJbtkvk12h_73ph-JpHo8fb2YeIQ8IU86z2YsenBn8NKOUiStylyATsUCRXv_TIzLxfg8ACDwBDrdkREVKM0zpHdlsP0208yZqbbRqeqeqsiuLIO3gy7bxUdlEfUA2znybpg_WkVzUuTu00aruKtX06mQvVVmFa-7JjVWVN5PLHJPdcrGdv8frj7fV_HUd6wSxj7N8ptAaBF0oyCjkNqUcGDXAlOFJgYAiXCsKDipPac50zhlnViuhmVaKjsnTObdz7ddgfC_37eCasFJSCG-iSFIM1POZ0q713hkrO1fWyh0kgjw2KM8NylODAX-8hA55bYo_-Lcv-gO23Gyj</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3020718241</pqid></control><display><type>article</type><title>The Use of Intralipid Infusions in the Prevention of Embryo Implantation Failure</title><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Anya, Okorie C ; Ajayi, Eniola R ; Solanke, Henry R ; Ohanaka, Adaeze I ; Ubana, Kokei D</creator><creatorcontrib>Anya, Okorie C ; Ajayi, Eniola R ; Solanke, Henry R ; Ohanaka, Adaeze I ; Ubana, Kokei D</creatorcontrib><description>Intralipids have been suggested to suppress uterine natural killer cell activity, which could potentially improve implantation rates in women with recurrent loss. We report a case of a 41-year-old African woman with recurrent pregnancy loss who had elevated uterine killer cell activity and for whom intralipid infusion was used to achieve pregnancy. We recommend routine uterine natural killer cell testing for women with recurrent pregnancy loss and further research on newer intravenous lipid emulsions in fertility medicine.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.53368</identifier><identifier>PMID: 38435143</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Antibodies ; Antigens ; Blood groups ; Cardiac arrest ; Case reports ; Embryos ; Endometrium ; Fertility ; Genotype &amp; phenotype ; Hepatitis ; HIV ; Human immunodeficiency virus ; Immune system ; In vitro fertilization ; Intensive care ; Lipids ; Lymphocytes ; Menstruation ; Nutrition ; Ovaries ; Parenteral nutrition ; Patients ; Pregnancy ; Serology ; Sperm ; Tumor necrosis factor-TNF</subject><ispartof>Curēus (Palo Alto, CA), 2024-02, Vol.16 (2), p.e53368</ispartof><rights>Copyright © 2024, Anya et al.</rights><rights>Copyright © 2024, Anya et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c211t-5b9a1fe10cda0530bf437063e06ae72d10187208d70ab43b6cb7676fca8c6caa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38435143$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anya, Okorie C</creatorcontrib><creatorcontrib>Ajayi, Eniola R</creatorcontrib><creatorcontrib>Solanke, Henry R</creatorcontrib><creatorcontrib>Ohanaka, Adaeze I</creatorcontrib><creatorcontrib>Ubana, Kokei D</creatorcontrib><title>The Use of Intralipid Infusions in the Prevention of Embryo Implantation Failure</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Intralipids have been suggested to suppress uterine natural killer cell activity, which could potentially improve implantation rates in women with recurrent loss. We report a case of a 41-year-old African woman with recurrent pregnancy loss who had elevated uterine killer cell activity and for whom intralipid infusion was used to achieve pregnancy. We recommend routine uterine natural killer cell testing for women with recurrent pregnancy loss and further research on newer intravenous lipid emulsions in fertility medicine.</description><subject>Antibodies</subject><subject>Antigens</subject><subject>Blood groups</subject><subject>Cardiac arrest</subject><subject>Case reports</subject><subject>Embryos</subject><subject>Endometrium</subject><subject>Fertility</subject><subject>Genotype &amp; phenotype</subject><subject>Hepatitis</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Immune system</subject><subject>In vitro fertilization</subject><subject>Intensive care</subject><subject>Lipids</subject><subject>Lymphocytes</subject><subject>Menstruation</subject><subject>Nutrition</subject><subject>Ovaries</subject><subject>Parenteral nutrition</subject><subject>Patients</subject><subject>Pregnancy</subject><subject>Serology</subject><subject>Sperm</subject><subject>Tumor necrosis factor-TNF</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpNkM1LAzEQxYMoVmpvnmXBq1tnNrtJepTSaqFgD-05ZLMJbtkvk12h_73ph-JpHo8fb2YeIQ8IU86z2YsenBn8NKOUiStylyATsUCRXv_TIzLxfg8ACDwBDrdkREVKM0zpHdlsP0208yZqbbRqeqeqsiuLIO3gy7bxUdlEfUA2znybpg_WkVzUuTu00aruKtX06mQvVVmFa-7JjVWVN5PLHJPdcrGdv8frj7fV_HUd6wSxj7N8ptAaBF0oyCjkNqUcGDXAlOFJgYAiXCsKDipPac50zhlnViuhmVaKjsnTObdz7ddgfC_37eCasFJSCG-iSFIM1POZ0q713hkrO1fWyh0kgjw2KM8NylODAX-8hA55bYo_-Lcv-gO23Gyj</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>Anya, Okorie C</creator><creator>Ajayi, Eniola R</creator><creator>Solanke, Henry R</creator><creator>Ohanaka, Adaeze I</creator><creator>Ubana, Kokei D</creator><general>Cureus Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20240201</creationdate><title>The Use of Intralipid Infusions in the Prevention of Embryo Implantation Failure</title><author>Anya, Okorie C ; Ajayi, Eniola R ; Solanke, Henry R ; Ohanaka, Adaeze I ; Ubana, Kokei D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c211t-5b9a1fe10cda0530bf437063e06ae72d10187208d70ab43b6cb7676fca8c6caa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antibodies</topic><topic>Antigens</topic><topic>Blood groups</topic><topic>Cardiac arrest</topic><topic>Case reports</topic><topic>Embryos</topic><topic>Endometrium</topic><topic>Fertility</topic><topic>Genotype &amp; phenotype</topic><topic>Hepatitis</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Immune system</topic><topic>In vitro fertilization</topic><topic>Intensive care</topic><topic>Lipids</topic><topic>Lymphocytes</topic><topic>Menstruation</topic><topic>Nutrition</topic><topic>Ovaries</topic><topic>Parenteral nutrition</topic><topic>Patients</topic><topic>Pregnancy</topic><topic>Serology</topic><topic>Sperm</topic><topic>Tumor necrosis factor-TNF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anya, Okorie C</creatorcontrib><creatorcontrib>Ajayi, Eniola R</creatorcontrib><creatorcontrib>Solanke, Henry R</creatorcontrib><creatorcontrib>Ohanaka, Adaeze I</creatorcontrib><creatorcontrib>Ubana, Kokei D</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anya, Okorie C</au><au>Ajayi, Eniola R</au><au>Solanke, Henry R</au><au>Ohanaka, Adaeze I</au><au>Ubana, Kokei D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Use of Intralipid Infusions in the Prevention of Embryo Implantation Failure</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2024-02-01</date><risdate>2024</risdate><volume>16</volume><issue>2</issue><spage>e53368</spage><pages>e53368-</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Intralipids have been suggested to suppress uterine natural killer cell activity, which could potentially improve implantation rates in women with recurrent loss. We report a case of a 41-year-old African woman with recurrent pregnancy loss who had elevated uterine killer cell activity and for whom intralipid infusion was used to achieve pregnancy. We recommend routine uterine natural killer cell testing for women with recurrent pregnancy loss and further research on newer intravenous lipid emulsions in fertility medicine.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>38435143</pmid><doi>10.7759/cureus.53368</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2024-02, Vol.16 (2), p.e53368
issn 2168-8184
2168-8184
language eng
recordid cdi_proquest_journals_3020718241
source PubMed Central Open Access; PubMed Central
subjects Antibodies
Antigens
Blood groups
Cardiac arrest
Case reports
Embryos
Endometrium
Fertility
Genotype & phenotype
Hepatitis
HIV
Human immunodeficiency virus
Immune system
In vitro fertilization
Intensive care
Lipids
Lymphocytes
Menstruation
Nutrition
Ovaries
Parenteral nutrition
Patients
Pregnancy
Serology
Sperm
Tumor necrosis factor-TNF
title The Use of Intralipid Infusions in the Prevention of Embryo Implantation Failure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T09%3A22%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Use%20of%20Intralipid%20Infusions%20in%20the%20Prevention%20of%20Embryo%20Implantation%20Failure&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Anya,%20Okorie%20C&rft.date=2024-02-01&rft.volume=16&rft.issue=2&rft.spage=e53368&rft.pages=e53368-&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.53368&rft_dat=%3Cproquest_cross%3E3020718241%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3020718241&rft_id=info:pmid/38435143&rfr_iscdi=true